All News

US biotechnology firm DOR BioPharma plans to build a bigger force in gastro-intestinal medicines by buying Copenhagen-based Gastrotech Pharma, a spin-out of Gothenburg University in Sweden.

With an estimated 400 million people at risk for developing dementia, a natural remedy would be a welcome answer. That's the approach one British company is taking.

"Basic research may seem very expensive. I am a well-paid scientist. My hourly wage is equal to that of a plumber..." Albert Szent-Györgyi, Nobel-winning chemist

The University of Cambridge is considering whether to make more cash available to invest in campus spin-off companies. And whatever decision it makes will come in for criticism…

Shares in Oxford BioMedica, an Oxford University spin-out, fell 8.3 percent on news that the company was seeking up to £30 million to fund the Phase III trial of its a TroVax cancer immunotherapy product.

Reports of incubators' demise were premature

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

A spin-out from the University of Southampton, UK, has a new “scintillation detector” that it says can help stop radiological threats at airports and elsewhere.

Physicists in Bangalore have developed new uses for carbon nanotubes – as flow sensors. Now they are looking for more licensees to develop their work.

New technology to repair the meniscus in the knee is under development at the University of Bristol, UK.

A novel procedure for the preparation of β-lactams, from non-natural substrates.

Undersea automation to deal with imaging, inspection, mapping, profiling, surveillance, classification and exploration.

This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.

A new class of antibiotics, to tackle MRSA and other multi-resistant organisms, is in development by a spin-off from the University of Surrey, UK.